Tissue PGE2 levels in studies comparing oral gavage and dietary administration of aspirin and the NSAID sulindac are lower after oral gavage, despite equivalent platelet COX-1 inhibition, suggesting that the duration and extent of tumour COX-2 inhibition in mice are highly dependent on the dosing route and schedule [38, 39]. The gene discussed is PTGS2; the disease is neoplasm.